attachment
attachment

Answers keep it Brief

I can see this is a Microbiology exam paper from M.S. Ramaiah Medical College (3rd Internal Assessment, June 2025). Let me answer all questions briefly.
Reading File
Given the budget constraints, I'll answer all questions directly from my medical knowledge. Here are brief answers to all exam questions:

LONG ESSAYS

Q1. Bronchoscope Disinfection (Spaulding's Classification)

A. Disinfectant Classes & Mechanism of Action:
ClassExampleMechanism
High-level disinfectantsGlutaraldehyde 2%, OPAAlkylates proteins/DNA
Intermediate-level70% Alcohol, IodophorsProtein denaturation, disrupts lipid membrane
Low-levelQuaternary ammonium compoundsDisrupts cell membrane
B. Spaulding's Classification:
  • Critical (enters sterile tissue): Sterilization required - e.g., surgical instruments
  • Semi-critical (contacts mucous membranes): High-level disinfection - e.g., bronchoscopes, endoscopes
  • Non-critical (contacts intact skin): Low/intermediate disinfection - e.g., BP cuffs, stethoscopes
C. Disinfecting Scopes (Bronchoscope):
  1. Pre-cleaning: wipe exterior, flush channels with water immediately after use
  2. Leak testing
  3. Manual cleaning: detergent solution, brush all channels
  4. Rinse
  5. High-level disinfection: immerse in 2% glutaraldehyde for 20-45 min (or OPA 12 min)
  6. Rinse with sterile/filtered water
  7. Dry with 70% alcohol flush + forced air
  8. Store hanging vertically
D. Testing Efficacy of Disinfectants:
  • Use-dilution test (AOAC method) - standard quantitative test
  • Kelsey-Sykes test - capacity use dilution test
  • Phenol coefficient - compare vs phenol as standard
  • In-use test - tests actual working dilution in hospital

Q2. Food Poisoning (Gram-negative, toxin-producing, invasive)

Agent: Vibrio parahaemolyticus (seafood) / also consider Shigella, but seafood + Gram-negative + invasive + toxin = Vibrio parahaemolyticus or E. coli (EHEC). Given mucus+blood+seafood = Vibrio parahaemolyticus.
A. Clinical Syndrome & Agents:
  • Gastroenteritis with vomiting, abdominal cramps, loose/bloody stools
  • Agents: Vibrio parahaemolyticus, V. cholerae O1/O139, Salmonella, Shigella
  • Toxin: Thermostable direct hemolysin (TDH) - Kanagawa phenomenon
B. Lab Diagnosis:
  • Specimen: Stool, rectal swab, vomitus, suspect food (seafood)
  • Gram stain: curved Gram-negative bacilli
  • Culture: Thiosulfate Citrate Bile Salt Sucrose (TCBS) agar - blue-green colonies
  • Oxidase positive
  • Salt tolerance (halophile) - 3% NaCl required
  • Serogrouping
C. Features of Dehydration:
  • Sunken eyes, dry mucous membranes, decreased skin turgor
  • Tachycardia, hypotension (severe)
  • Oliguria, concentrated urine
  • Altered consciousness (severe)
  • WHO grades: No dehydration / Some dehydration / Severe dehydration
D. Rationale of ORS:
  • Glucose-sodium co-transport (SGLT1) in intestinal epithelium remains intact even during secretory diarrhea
  • Glucose actively pulls Na+ and water into enterocytes
  • WHO ORS: Na 75 mEq/L, K 20 mEq/L, Chloride 65 mEq/L, Citrate 10 mEq/L, Glucose 75 mmol/L

SHORT ESSAYS

Q3. Fasciola hepatica (3+2)

Life Cycle:
  • Definitive host: sheep, cattle, humans
  • Intermediate host: Lymnaea snail
  • Eggs → miracidium → sporocyst → redia → cercaria (in snail) → metacercaria on aquatic vegetation → ingested by human → excyst in duodenum → migrate through liver parenchyma → bile ducts (adult)
Clinical Manifestations:
  • Acute: fever, RUQ pain, hepatomegaly, eosinophilia (migratory phase)
  • Chronic: biliary obstruction, cholangitis, cholecystitis
  • Halzoun: pharyngeal fascioliasis from raw liver

Q4. Herpes Simplex Virus (2+3)

Clinical Manifestations:
  • HSV-1: gingivostomatitis, herpes labialis, keratoconjunctivitis, encephalitis
  • HSV-2: genital herpes, neonatal herpes
  • Both: herpetic whitlow, eczema herpeticum
Lab Diagnosis:
  • Tzanck smear: multinucleated giant cells
  • Culture: CPE in 24-48 hrs (rounding, ballooning)
  • PCR (gold standard for encephalitis - CSF)
  • Direct immunofluorescence (DFA)
  • Serology: IgM (primary), IgG (past infection)

Q5. Subcutaneous Mycoses (2+3)

Aetiology:
  • Sporotrichosis: Sporothrix schenckii (rose thorn prick)
  • Chromoblastomycosis: Fonsecaea, Cladosporium
  • Mycetoma (Madura foot): Madurella mycetomatis
  • Rhinosporidiosis: Rhinosporidium seeberi
Lab Diagnosis:
  • Direct microscopy: KOH mount
  • Sporotrichosis: culture on SDA - cigar-shaped yeast at 37°C
  • Chromoblastomycosis: sclerotic bodies (Medlar/copper penny bodies)
  • Mycetoma: grains in pus (color varies by agent)

Q6. Primary vs Secondary Immune Response

FeaturePrimarySecondary
Antigen exposure1st2nd (same Ag)
Lag period5-7 days1-3 days
Peak antibodyLowerMuch higher
Antibody classIgM first, then IgGPredominantly IgG
AffinityLowerHigher (affinity maturation)
DurationShorterLonger
Cells involvedNaive B cellsMemory B cells

Q7. Biological Effects of Complement

  • Opsonization: C3b coats bacteria → phagocytosis
  • Chemotaxis: C3a, C5a attract neutrophils
  • Anaphylatoxins: C3a, C4a, C5a → mast cell degranulation → inflammation
  • Membrane Attack Complex (MAC): C5b-9 → lysis of Gram-negative bacteria
  • Immune complex clearance: CR1 on RBCs transport complexes to liver/spleen
  • Enhancement of antibody production: C3d on B cell receptor

Q8. Lymphatic Filariasis (2+3)

Clinical Manifestations:
  • Acute: fever, lymphangitis (retrograde), lymphadenitis
  • Chronic: lymphedema, elephantiasis (lower limbs, scrotum), hydrocele, chyluria
  • Tropical pulmonary eosinophilia (TPE)
Lab Diagnosis:
  • Peripheral blood smear: nocturnal periodicity - collect blood at night (10 pm-2 am); Mf (microfilariae) in sheathed form
  • Knott's concentration technique
  • Membrane filtration
  • Antigen detection: ICT card test (circulating filarial antigen)
  • Serology: ELISA
  • PCR

SHORT ANSWERS

9. Immunofluorescence in Virology:
  • Direct IF: labeled antibody detects viral antigen in cells (e.g., RSV, Influenza DFA)
  • Indirect IF: unlabeled primary Ab + labeled secondary Ab; more sensitive
10. Premunition: Resistance to new infection while existing infection persists. Example: Plasmodium - mild immunity in chronic malaria prevents severe re-infection; disappears when infection clears.
11. Active vs Passive Immunity (3 differences):
ActivePassive
Body produces own antibodiesPre-formed antibodies given
Slow onset (days-weeks)Immediate onset
Long-lasting (years/lifelong)Short-lived (weeks-months)
12. Acute Osteomyelitis - Bacterial:
  • Commonest organism: Staphylococcus aureus
  • Haematogenous spread to metaphysis
  • Features: fever, localized bone pain, tenderness, swelling
  • Lab: elevated ESR/CRP, blood culture, bone biopsy culture
  • X-ray changes appear after 10-14 days; MRI is early investigation of choice
13. Darling's Disease (Histoplasmosis):
  • Caused by Histoplasma capsulatum
  • Dimorphic fungus; yeast in tissue (intracellular in macrophages)
  • Endemic in Ohio/Mississippi River Valley
  • Diagnosis: Giemsa stain of bone marrow/blood; culture on SDA; urinary antigen test
14. Enterotest (String Test):
  • Used to collect duodenal contents for Giardia / Strongyloides
  • Gelatin capsule with nylon string swallowed; free end taped to cheek
  • After 4 hours, string retrieved and bile-stained portion examined microscopically
15. Ectothrix & Endothrix:
  • Ectothrix: arthroconidia on the outside of hair shaft (e.g., Microsporum canis, T. verrucosum)
  • Endothrix: arthroconidia inside hair shaft (e.g., T. tonsurans, T. violaceum)
16. Erythema Infectiosum (Fifth Disease):
  • Caused by Parvovirus B19
  • "Slapped cheek" appearance; lacy reticular rash on trunk/limbs
  • Aplastic crisis in sickle cell disease
  • Hydrops fetalis if in pregnancy
17. Cold Abscess - Spine (Pott's Disease):
  • Tuberculous spondylitis; L1 most common
  • Cold abscess: no heat/redness (unlike pyogenic); tracks along psoas muscle → psoas abscess
  • Features: back pain, gibbus deformity, paraplegia (Pott's paraplegia)
  • Diagnosis: MRI spine (gold standard), AFB culture of abscess aspirate
18. Beneficence:
  • Medical ethics principle: duty to act in the best interest of the patient
  • Do good, provide benefit, balance risks and benefits
  • Contrast with Non-maleficence ("do no harm")

All 18 questions answered. Good luck with your exam!
This is a shared conversation. Sign in to Orris to start your own chat.